Rocking Penny Stocks Brings You Hot Trending Stocks to Watch - ACTC, CBAI, GMEC, AHFD

Lakeland, FL -- (SBWIRE) -- 01/23/2013 -- Rocking Penny Stocks is an organization specializing in market analysis and news assessment and is is dedicated to diligently striving to insure that our subscribers are better informed investors. At Rocking Penny Stocks, we focus on discovering the Best Penny Stocks with substantial growth potential.

Advanced Cell Technology, Inc. (OTC:ACTC) opened at the price of $0.09 for the day. Its closing price was $0.0851 after losing -3.41% for the day. The company traded with the total volume of 16.03 million shares, while its average trading volume remained 12.53 million shares. The beta of ACTC stands at -2.01.

Have a look at the company’s graph:

During the last 5 trades, the stock jumped almost 4.8%. During the last one month it rose with the percentage of 41.83%. Its year to date performance remained up 52.78%.

The 52-week price range of the stock remained $0.05 - $0.20, while during last trade its minimum price was $0.09 and it gained its highest price of $0.09.

Will ACTC Get Buyers Even After The Recent Rally? Find Out Here

Cord Blood America Inc. (OTC:CBAI) percentage change rose 3.70%, to close at $0.0028 with the total traded volume of 12.56 million shares, more than average volume of 9.14 million.

The Company’s year to date performance remained negative as it lost almost -44%. If we look at its last 6 months of trade, that is in the bearish zone with a drop of -80.28%

Its beta value stands at -0.48 times and earnings per share was $-0.02. The company has a total of 250 million outstanding shares and its total market capitalization is $699,998

The 52-week price range of the stock remained $0.00 - $0.05, while during last trade its minimum price was $0.00 and it gained its highest price of $0.00.

What was the Moving Force behind CBAI's Bullish Run? Read This Research Report

Great East Bottles & Drinks Hldgs (OTC:GMEC) started its trading session with the price $0.07 and closed at $0.0901 after scoring +52.71%. Day trading range of GMEC was $0.07 -$0.11.

A review of its graph:

Previous 5 days graph demonstrated a positive move of 104.77%. GMEC’s quarterly performance remained in the green with the percentage gain of 125.25, while its year to date performance showed that the stock advanced overall 12.62%. The beta of GMEC stands at 3.99.

GMEC’s stocks traded with total volume of 10.18 million shares, while the average trading capacity remained 297,828shares.

Will GMEC Continue To Move Higher? Find Out Here

Active Health Foods, Inc. (OTC:AHFD) closed at $0.0010 during the previous trading session, while the stock showed no change for the day.

Graph values of the stock demonstrate these trends:

In the last 5 days of trading, the stock went up and scored more than 11%, while in its last one month of trading it declined more than 28%. AHFD traded with volume of 9.69 million shares, while its average trading volume remained 16.11 million shares.

Currently, the company has a market capitalization of $405,300. Stock’s closing price was $0.0010.

Is AHFD a Solid Investment at These Levels? Read This Report For Details

About Rocking Penny Stocks
At Rocking Penny Stocks, we focus on discovering stocks with substantial growth potential. We search for microcap stocks able to generate aggressive short and long term gains when driven by time sensitive news and events. Now you might be asking what it is that makes microcap stocks rise in value so quickly. It is almost always because of positive news announcements about the company. Get the hottest microcap stock alerts, news and information right here! Join our free Penny Stock newsletter.

Disclaimer
The assembled information disseminated by rockingpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Rockingpennystocks.com does not expect that investors will buy and sell securities based on information assembled and presented in Rockingpennystocks.com. PLEASE, always do your own due diligence and consult your financial advisor.